Local Institution

Arequipa, Arequipa 54

0 studies enrolling now · 6 studies all time

What they study most

Breast Cancer, Diabetes Mellitus, Diabetes Mellitus, Type 2, Metabolics Diabetes Nos, Metastasis, Myeloid Leukemia, Chronic, Type 2 Diabetes

Studies at this site

• A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia — Completed
• Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment — Completed
• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker — Completed
• PPAR - Combination With Metformin — Completed
• Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-positive (ER+/PR+) or Her2/Neu-positive (Her2/Neu+)Breast Cancer — Completed
• PPAR-COMBO With Sulfonylurea — Completed